Marina Biotech Raises $6M in Conv Preferred Deal at 41% Discount

Marina Biotech, Inc. (MRNA) announced that it has raised $6,000,000 in a Convertible Preferred Stock transaction. The fixed conversion price of the Convertible Preferred Stock is $0.75 per share, an approximate 40.94% discount to the market price ($1.27) of MRNA at deal announcement. A series of 6,000,000 60-Month Warrants with an exercise price of $0.75 per share (40.94% discount) was issued to the investors in this transaction. Note this Placement is subject to customary closing conditions and is expected to close by 03/07/2014. via PlacementTracker.

Osage Exploration and Development Raises $4.4M at 17% Discount via Cabot Lodge Securities

Osage Exploration and Development Inc. (OEDV) announced that it has raised $4,410,000 in a Common Stock transaction. The common stock was sold at $0.90 per share, an approximate 17% discount to the market price ($1.09) of OEDV at deal announcement. A series of 1,960,000 60-Month Warrants with an exercise price of $1.80 per share (65.14% premium) was issued to the investors in this transaction. Cabot Lodge Securities, LLC acted as the exclusive agent on the transaction. Issuer counsel was McConnell, Dunning & Barwick LLP.

Be Active Holdings Raises $1M at 83% Discount

Be Active Holdings Inc. (JALA) announced that it has raised $1,000,000 in a Common Stock transaction. The common stock was sold at $0.03 per share, an approximate 83% discount to the market price ($0.17) of JALA at deal announcement. A series of 59,999,999 60-Month Warrants with an exercise price of $0.03 per share (82.76% discount) was issued to the investors in this transaction. Issuer counsel was Sichenzia Ross Friedman Ference. The transaction closed on February 18, 2014.

Cannabis Science Raises $1M at 32% Premium

Cannabis Science Inc. (CBIS) announced that it has raised $1,000,000 in a Units (Common Stock + Warrants) transaction. The common stock was sold at $0.25 per share, an approximate 32% premium to the market price ($0.19) of CBIS at deal announcement. A series of 27,778 12-Month Warrants with an exercise price of $0.50 per share (163.16% premium) was issued to the investors in this transaction. via PlacementTracker.